N4 Pharma Plc
N4 Pharma Plc, a specialist pharmaceutical company, develops and licenses novel silica nanoparticle delivery system for vaccines and therapeutics in the United Kingdom. It develops Nuvec, an engineered silica nanoparticle for use in intracellular delivery of large nucleic acids, such as pDNA and mRNA and improves the effectiveness of viral vaccines. The company has a research collaboration with Nanomerics Ltd to develop and formulate Nuvec system. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom. Show More...
-
Website http://www.n4pharma.com
-
Sector Healthcare
-
Industry Drug Manufacturers-Specialty & Generic
-
Last Quote 0.48 GBX
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share GBP 0.04 0.07 0.02 -0.02 -0.34 -0.09 -0.03 -0.010 -0.010 -0.010 Dividends GBP Payout Ratio % * Shares Mil 7.0 7.0 7.0 7.0 7.0 12.0 35.0 66.0 91.0 100.0 100.0 Book Value Per Share * GBP 0.43 0.46 0.52 0.5 0.47 0.03 0.02 0.02 0.02 0.010 0.010 Free Cash Flow Per Share * GBP -0.03 0.03 -0.08 -0.010 -0.03 -0.07 -0.03 -0.02 -0.010 -0.010 Return on Assets % 9.36 11.55 2.77 -3.39 -77.19 -84.0 -2.48 -142.57 -93.7 -82.09 -82.09 Financial Leverage (Average) 1.35 1.42 1.34 1.26 1.77 1.03 1.07 1.14 1.22 1.08 1.08 Return on Equity % 13.04 16.04 3.83 -4.42 -106.54 -125.13 -2.62 -158.31 -109.72 -93.87 -93.87 Return on Invested Capital % 12.51 14.9 3.76 -4.28 -94.03 -106.15 -3.33 -157.87 -109.65 -93.73 -93.73 Interest Coverage 118.67 162.0 8.1 -29.67 -496.4 -40.0 -362.63 -684.0 -684.0 Current Ratio 1.66 1.06 1.5 1.76 1.53 35.76 7.81 8.14 5.63 13.71 13.71 Quick Ratio 1.13 0.64 0.99 0.99 0.99 34.59 4.77 8.14 4.18 12.45 12.45 Debt/Equity